​

Funding Round

Series B - Apitope

Series B - Apitope

Investment Firm

Overview

Apitope is a European biotech company

Announced Date

Sep 29, 2015

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

Arthurian Life Sciences

Arthurian Life Sciences

No designation

Participant Investors

5

Investor Name
Participant InvestorWyvern Seed Fund
Participant InvestorArthurian Life Sciences
Participant InvestorVesalius Biocapital Partners
Participant InvestorLimburgse Reconversie Maatschappij
Participant InvestorPMV Pharmaceuticals

Round Details and Background

Apitope raised $13507444 on 2015-09-29 in Series B

Apitope is a European biotech company

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 21, 2012
Grant - Apitope
-undefined
Oct 30, 2008
Series A - Apitope
2-12.9M
Sep 29, 2015
Series B - Apitope
5-13.5M

Recent Activity

There is no recent news or activity for this profile.